Obesity Global Clinical Trial Landscape (2025)

Download this free, data-driven report to explore the latest developments in the global obesity clinical trial landscape in 2025, offering valuable insights into novel therapies, ongoing clinical trials, and future innovations shaping its treatment. The report features information on current fields of research, including how advances in obesity treatment and biomarkers are driving more targeted and effective interventions. GLP-1 receptor agonists, for example, remain central to therapy, while dual/triple GLP-1/GIP agonists are offering enhanced weight loss. Download now to find out more.